Jupiter Fund Management plc (LON:JUP) Lost It’s Barclays Capital “” Rating; BAVARIAN NORDIC RESEARCH INSTITUTE ORDIN (BVNKF) SI Increased By 6.97%

Bavarian Nordic A/S (OTCMKTS:BVNKF) Logo

In a analysts report revealed to clients on 27 April, Barclays Capital has decreased Jupiter Fund Management plc (LON:JUP) stock to a “Underweight” and has set a 12 month target price per share at GBX 395.00. Barclays Capital’s target is -12.29% from JUP’s last price.

BAVARIAN NORDIC RESEARCH INSTITUTE ORDIN (OTCMKTS:BVNKF) had an increase of 6.97% in short interest. BVNKF’s SI was 508,200 shares in April as released by FINRA. Its up 6.97% from 475,100 shares previously. The SI to BAVARIAN NORDIC RESEARCH INSTITUTE ORDIN’s float is 1.69%. It closed at $35.35 lastly. It is down 0.00% since April 27, 2017 and is . It has underperformed by 11.55% the S&P500.

Bavarian Nordic A/S, a biotechnology company, develops, makes, and commercializes a portfolio of novel vaccines for the prevention and treatment of life-threatening infectious diseases and cancer. The company has market cap of $903.32 million. The firm markets non-replicating smallpox vaccine under the IMVAMUN and IMVANE names. It has a 37.61 P/E ratio. It is also developing MVA-BN Filo that is in Phase III trial for the treatment of Ebola and Marburg; MVA-BN RSV, which is in Phase II clinical development stage for the prevention of respiratory syncytial virus; and MVA-BN HPV that is in preclinical development stage to treat human papillomavirus.

Among 19 analysts covering Jupiter Fund Management plc (LON:JUP), 2 have Buy rating, 6 Sell and 11 Hold. Therefore 11% are positive. Jupiter Fund Management plc has GBX 664 highest and GBX 345 lowest target. GBX 506.63’s average target is 12.56% above currents GBX 450.1 stock price. Jupiter Fund Management plc had 188 analyst reports since July 29, 2015 according to SRatingsIntel. On Wednesday, November 11 the stock rating was upgraded by Barclays Capital to “Overweight”. Barclays Capital maintained Jupiter Fund Management Plc (LON:JUP) on Thursday, July 28 with “Equal Weight” rating. Liberum Capital maintained it with “Buy” rating and GBX 664 target in Thursday, January 11 report. Barclays Capital maintained the stock with “Equal Weight” rating in Tuesday, October 13 report. The firm has “Equal Weight” rating given on Thursday, July 21 by Barclays Capital. The stock of Jupiter Fund Management Plc (LON:JUP) earned “Buy” rating by Jefferies on Monday, April 10. Peel Hunt maintained it with “Hold” rating and GBX 600 target in Tuesday, February 27 report. Numis Securities maintained Jupiter Fund Management Plc (LON:JUP) on Thursday, January 12 with “Add” rating. The firm has “Buy” rating given on Friday, February 24 by Liberum Capital. The firm has “Hold” rating by Numis Securities given on Friday, September 1.

The stock decreased 1.16% or GBX 5.3 during the last trading session, reaching GBX 450.1. About 643,582 shares traded. Jupiter Fund Management Plc (LON:JUP) has 0.00% since April 27, 2017 and is . It has underperformed by 11.55% the S&P500.

Jupiter Fund Management Plc is a publicly owned investment manager. The company has market cap of 2.02 billion GBP. The firm manages mutual funds, hedge funds, client focused portfolios, and multi-manager products for its clients. It has a 13.36 P/E ratio. It invests in the public equity markets across U.K., Europe and global emerging markets.